Academic Journal
Proteogenomic studies in epithelial ovarian cancer: established knowledge and future needs
| Τίτλος: | Proteogenomic studies in epithelial ovarian cancer: established knowledge and future needs |
|---|---|
| Συγγραφείς: | Jacob, Francis, Goldstein, Darlene R., Fink, Daniel, Heinzelmann-Schwarz, Viola |
| Έτος έκδοσης: | 2010 |
| Συλλογή: | Ecole Polytechnique Fédérale Lausanne (EPFL): Infoscience |
| Θεματικοί όροι: | biomarkers, diagnostics, glycomics, microarray, ovarian cancer, ovary, post-translational modifications, profiling, proteomics, transcriptomics, Gene-Expression Profiles, Complementary-Dna Microarray, Probe Level Data, Mass-Spectrometry, Serous Carcinoma, Cdna Microarray, Fallopian-Tube, Breast-Cancer, Discovery |
| Περιγραφή: | There has been a concerted effort over the last decade to improve our understanding of the complex biology of ovarian cancer. A linear growth in published proteogenomic studies has addressed a variety of questions regarding its molecular pathogenesis. A number of genes have been identified by transcriptomic approaches, some of which are being investigated as putative tumor markers (HE4, OPN, Ep-CAM and Mesothelin), whilst others are potential targets for molecular therapeutic approaches (VEGF, 104, EGFR, MUC1, CLDN4 and SLPI). Proteogenomics has the potential to further change our current characterization and treatment of ovarian cancer. Additional advances will depend on integrated study designs, interdisciplinary collaborations, use of robust high-throughput platforms, as well as uniform guidelines for bioinformatic analyses. ; STAT |
| Τύπος εγγράφου: | article in journal/newspaper |
| Γλώσσα: | unknown |
| Relation: | Biomarkers In Medicine; https://infoscience.epfl.ch/handle/20.500.14299/59492; WOS:000273409100017 |
| DOI: | 10.2217/BMM.09.48 |
| Διαθεσιμότητα: | https://doi.org/10.2217/BMM.09.48 https://infoscience.epfl.ch/handle/20.500.14299/59492 https://hdl.handle.net/20.500.14299/59492 |
| Αριθμός Καταχώρησης: | edsbas.24CF348D |
| Βάση Δεδομένων: | BASE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://doi.org/10.2217/BMM.09.48# Name: EDS - BASE (ns324271) Category: fullText Text: View record from BASE |
|---|---|
| Header | DbId: edsbas DbLabel: BASE An: edsbas.24CF348D RelevancyScore: 771 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 771.324340820313 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Proteogenomic studies in epithelial ovarian cancer: established knowledge and future needs – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Jacob%2C+Francis%22">Jacob, Francis</searchLink><br /><searchLink fieldCode="AR" term="%22Goldstein%2C+Darlene+R%2E%22">Goldstein, Darlene R.</searchLink><br /><searchLink fieldCode="AR" term="%22Fink%2C+Daniel%22">Fink, Daniel</searchLink><br /><searchLink fieldCode="AR" term="%22Heinzelmann-Schwarz%2C+Viola%22">Heinzelmann-Schwarz, Viola</searchLink> – Name: DatePubCY Label: Publication Year Group: Date Data: 2010 – Name: Subset Label: Collection Group: HoldingsInfo Data: Ecole Polytechnique Fédérale Lausanne (EPFL): Infoscience – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22biomarkers%22">biomarkers</searchLink><br /><searchLink fieldCode="DE" term="%22diagnostics%22">diagnostics</searchLink><br /><searchLink fieldCode="DE" term="%22glycomics%22">glycomics</searchLink><br /><searchLink fieldCode="DE" term="%22microarray%22">microarray</searchLink><br /><searchLink fieldCode="DE" term="%22ovarian+cancer%22">ovarian cancer</searchLink><br /><searchLink fieldCode="DE" term="%22ovary%22">ovary</searchLink><br /><searchLink fieldCode="DE" term="%22post-translational+modifications%22">post-translational modifications</searchLink><br /><searchLink fieldCode="DE" term="%22profiling%22">profiling</searchLink><br /><searchLink fieldCode="DE" term="%22proteomics%22">proteomics</searchLink><br /><searchLink fieldCode="DE" term="%22transcriptomics%22">transcriptomics</searchLink><br /><searchLink fieldCode="DE" term="%22Gene-Expression+Profiles%22">Gene-Expression Profiles</searchLink><br /><searchLink fieldCode="DE" term="%22Complementary-Dna+Microarray%22">Complementary-Dna Microarray</searchLink><br /><searchLink fieldCode="DE" term="%22Probe+Level+Data%22">Probe Level Data</searchLink><br /><searchLink fieldCode="DE" term="%22Mass-Spectrometry%22">Mass-Spectrometry</searchLink><br /><searchLink fieldCode="DE" term="%22Serous+Carcinoma%22">Serous Carcinoma</searchLink><br /><searchLink fieldCode="DE" term="%22Cdna+Microarray%22">Cdna Microarray</searchLink><br /><searchLink fieldCode="DE" term="%22Fallopian-Tube%22">Fallopian-Tube</searchLink><br /><searchLink fieldCode="DE" term="%22Breast-Cancer%22">Breast-Cancer</searchLink><br /><searchLink fieldCode="DE" term="%22Discovery%22">Discovery</searchLink> – Name: Abstract Label: Description Group: Ab Data: There has been a concerted effort over the last decade to improve our understanding of the complex biology of ovarian cancer. A linear growth in published proteogenomic studies has addressed a variety of questions regarding its molecular pathogenesis. A number of genes have been identified by transcriptomic approaches, some of which are being investigated as putative tumor markers (HE4, OPN, Ep-CAM and Mesothelin), whilst others are potential targets for molecular therapeutic approaches (VEGF, 104, EGFR, MUC1, CLDN4 and SLPI). Proteogenomics has the potential to further change our current characterization and treatment of ovarian cancer. Additional advances will depend on integrated study designs, interdisciplinary collaborations, use of robust high-throughput platforms, as well as uniform guidelines for bioinformatic analyses. ; STAT – Name: TypeDocument Label: Document Type Group: TypDoc Data: article in journal/newspaper – Name: Language Label: Language Group: Lang Data: unknown – Name: NoteTitleSource Label: Relation Group: SrcInfo Data: Biomarkers In Medicine; https://infoscience.epfl.ch/handle/20.500.14299/59492; WOS:000273409100017 – Name: DOI Label: DOI Group: ID Data: 10.2217/BMM.09.48 – Name: URL Label: Availability Group: URL Data: https://doi.org/10.2217/BMM.09.48<br />https://infoscience.epfl.ch/handle/20.500.14299/59492<br />https://hdl.handle.net/20.500.14299/59492 – Name: AN Label: Accession Number Group: ID Data: edsbas.24CF348D |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsbas&AN=edsbas.24CF348D |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2217/BMM.09.48 Languages: – Text: unknown Subjects: – SubjectFull: biomarkers Type: general – SubjectFull: diagnostics Type: general – SubjectFull: glycomics Type: general – SubjectFull: microarray Type: general – SubjectFull: ovarian cancer Type: general – SubjectFull: ovary Type: general – SubjectFull: post-translational modifications Type: general – SubjectFull: profiling Type: general – SubjectFull: proteomics Type: general – SubjectFull: transcriptomics Type: general – SubjectFull: Gene-Expression Profiles Type: general – SubjectFull: Complementary-Dna Microarray Type: general – SubjectFull: Probe Level Data Type: general – SubjectFull: Mass-Spectrometry Type: general – SubjectFull: Serous Carcinoma Type: general – SubjectFull: Cdna Microarray Type: general – SubjectFull: Fallopian-Tube Type: general – SubjectFull: Breast-Cancer Type: general – SubjectFull: Discovery Type: general Titles: – TitleFull: Proteogenomic studies in epithelial ovarian cancer: established knowledge and future needs Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jacob, Francis – PersonEntity: Name: NameFull: Goldstein, Darlene R. – PersonEntity: Name: NameFull: Fink, Daniel – PersonEntity: Name: NameFull: Heinzelmann-Schwarz, Viola IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Type: published Y: 2010 Identifiers: – Type: issn-locals Value: edsbas |
| ResultId | 1 |